Table 2.

Correlates of VF among fisherfolk on first-line ART in Uganda

Characteristic	VL ≥1000 copies/mL, n/N (%)	Unadjusted OR (95% CI)	P value	aOR	P value
Gender
male	47/521 (9.0)	1
female	50/648 (7.7)	0.84 (0.56–1.29)	0.422	0.82 (0.53–1.25)	0.350
a Age group (years)
<35	52/513 (10.1)	1
≥35	45/656 (6.9)	0.65 (0.43–0.99)	0.045	0.64 (0.41–0.97)	0.042
Education level			0.056		0.043
never	13/189 (6.9)	1
primary	72/907 (7.9)	1.17 (0.63–2.15)	0.620	1.08 (0.58–2.00)	0.807
secondary/higher	12/73 (16.4)	2.66 (1.15–6.15)	0.022	2.42 (1.04–5.64)	0.041
b Marital status
married	57/712 (8.0)	1
not married	40/457 (8.7)	1.10 (0.72–1.68)	0.651
a ART regimen
NVP versus EFV (NNRTIs)
NVP-based	31/295 (10.5)	1
EFV-based	66/880 (7.5)	0.70 (0.44–1.09)	0.048	0.59 (0.34–0.91)	0.020
TDF versus ZDV (NRTIs)
TDF + 3TC + EFV/NVP	65/873 (7.4)	1
ZDV + 3TC + EFV/NVP	32/282 (11.3)	1.59 (1.02–2.49)	0.041	2.10 (1.29–3.46)	0.003
Median months on ART
≤12	47/474 (9.9)	1
≥24	50/694 (7.2)	0.71 (0.47–1.07)	0.113	0.61 (0.39–0.97)	0.035

3TC, lamivudine; EFV, efavirenz; NVP, nevirapine; TDF, tenofovir; ZDV, zidovudine. Statistically significant P values are shown in bold.

We classified the ART regimen into two categories, i.e. an NNRTI component (nevirapine-based versus efavirenz-based) and the second category based on the NRTI component (tenofovir versus zidovudine). We report P values of other variables in the model where the NNRTI component was included, although the statistical significance of the listed variables was maintained in the model in which we included the NRTI component (logistic regression model results of other variables were excluded except for NRTI variables in this case).

^aOnly variables with a P value of ≤0.15 and a priori confounders (gender and age) were included in multivariate regression models.

^bNot married means single, divorced or separated.